Literature DB >> 27265101

Factor V 1691 G-A mutation distribution in a healthy Turkish population.

Namık Özbek1.   

Abstract

The aim of this review was to compile published data on factor V 1691 G-A alteration in a healthy Turkish population and also to stimulate the reporting of unpublished data, in order to create a map for factor V Leiden (FVL) in Turkey. From a total of 4276 healthy individuals from 26 different centers of Turkey, 345 FVL carriers (7.9%) were determined. FVL was strikingly high among newborns from two different centers (10.9%).

Entities:  

Year:  2009        PMID： 27265101

Source DB:  PubMed          Journal:  Turk J Haematol        ISSN： 1300-7777            Impact factor:   1.831


  6 in total

1.  Factor V Leiden 1691G/A and prothrombin gene 20210G/A polymorphisms as prothrombotic markers in adult Egyptian acute leukemia patients.

Authors:  Azza Hamdy El Sissy; Maha H El Sissy; Shereef Elmoamly
Journal:  Med Oncol       Date:  2014-09-27       Impact factor: 3.064

2.  Spontaneously developed paraplegia in a patient with Factor V Leiden mutation.

Authors:  Ismail Boyraz; Bunyamin Koc; Sirzat Cogalgil
Journal:  Spinal Cord Ser Cases       Date:  2016-04-07

3.  A novel protein C inhibitor gene mutation in pediatric stroke patients after bone marrow transplantation.

Authors:  Didem Torun; Gülhis Deda; Mehmet Ertem; Zümrüt Uysal; Erkan Yılmaz; Nejat Akar
Journal:  Mol Biol Rep       Date:  2013-05-14       Impact factor: 2.316

4.  The prevalence of Factor V Leiden, prothrombin G20210A, MTHFR C677T and MTHFR A1298C mutations in healthy Turkish population.

Authors:  M Ekim; H Ekim; Y K Yılmaz
Journal:  Hippokratia       Date:  2015 Oct-Dec       Impact factor: 0.471

5.  Factor V Leiden Mutation Frequency and Geographical Distribution in Turkish Population.

Authors:  Eray Yıldız; Funda Müşerref Türkmen
Journal:  J Transl Int Med       Date:  2020-12-31

6.  Factor V Leiden and Prothrombin 20210A Mutations among Turkish Pediatric Leukemia Patients.

Authors:  Dilara Fatma Akın; Kadir Sipahi; Tuğba Kayaalp; Yonca Eğin; Serpil Taşdelen; Emin Kürekçi; Ustün Ezer; Nejat Akar
Journal:  Leuk Res Treatment       Date:  2012-02-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.